近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Dines, J. A., & Marson, C. M. (2016). A direct alkylation route to branched derivatives of suberoylanilide hydroxamic acid (SAHA), a potent non-selective inhibitor of histone deacetylases. Tetrahedron, 72 (52), 8584-8592. doi:10.1016/j.tet.2016.11.039
Promontorio, R., Richard, J. -. A., & Marson, C. M. (2016). Domino Michael-aldol annulations for the stereocontrolled synthesis of bicyclo[3.3.1]nonane and bicyclo[3.2.1]octane derivatives. RSC Adv., 6 (115), 114412-114424. doi:10.1039/C6RA23523A
Greenwood, S. O. R. (2015). Design and evaluation of novel histone deacetylase 8 inhibitors (Doctoral dissertation). UCL (University College London).
Marson, C. M., Matthews, C. J., Atkinson, S. J., Lamadema, N., & Thomas, N. S. B. (2015). Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit. JOURNAL OF MEDICINAL CHEMISTRY, 58 (17), 6803-6818. doi:10.1021/acs.jmedchem.5b00545
Ferretti, P., Pong, K. U., Vagaska, B., Merchant, R., Matthews, C. J., & Marson, C. M. (2013). Discovery of a structurally novel, drug-like and potent inhibitor of peptidylarginine deiminase. MEDCHEMCOMM, 4 (7), 1109-1113. doi:10.1039/c3md00091e
Marson, C. M., Matthews, C. J., Yiannaki, E., Atkinson, S. J., Soden, P. E., Shukla, L., . . . Thomas, N. S. B. (2013). Discovery of Potent, Isoform-Selective Inhibitors of Histone Deacetylase Containing Chiral Heterocyclic Capping Groups and a N-(2-Aminophenyl)benzamide Binding Unit. JOURNAL OF MEDICINAL CHEMISTRY, 56 (15), 6156-6174. doi:10.1021/jm400634n
Ostovar, M., & Marson, C. M. (2013). Enynone dihydroxylation-cyclisation as a route to densely functionalised 3(2H)-furanone derivatives: an approach to the core of the zaragozic acids. TETRAHEDRON, 69 (32), 6639-6647. doi:10.1016/j.tet.2013.05.125
Maharaj, L., Marson, C. M., Middleton, B. J., Rioja, A. S., Perry, J., Oakervee, H., . . . Popat, R. (2013). The histone deacetylase inhibitor UCL67022 has potent activity in multiple myeloma and non-Hodgkin lymphoma pre-clinical models. Br J Haematol, 163 (1), 135-139. doi:10.1111/bjh.12456
Marson, C. M. (2012). Multicomponent and sequential organocatalytic reactions: diversity with atom-economy and enantiocontrol. CHEMICAL SOCIETY REVIEWS, 41 (23), 7712-7722. doi:10.1039/c2cs35183h
Marson, C. M. (2011). New and unusual scaffolds in medicinal chemistry. CHEMICAL SOCIETY REVIEWS, 40 (11), 5514-5533. doi:10.1039/c1cs15119c
Marson, C. M. (2011). Targeting the Histamine H-4 Receptor. CHEMICAL REVIEWS, 111 (11), 7121-7156. doi:10.1021/cr900166w
Assem, E. S. K., Mann, S., Wan, B. Y. C., & Marson, C. M. (2010). Effect of antioxidants on airway smooth muscle contraction: action of lipoic acid and some of its novel derivatives on guinea pig tracheal smooth muscle. INFLAMMATION RESEARCH, 59, 235-237. doi:10.1007/s00011-009-0137-0
Wan, B. Y. C., Mann, S., Assem, E. S. K., & Marson, C. M. (2010). Effect of endogenous and synthetic antioxidants on hydrogen peroxide-induced guinea-pig colon contraction. INFLAMMATION RESEARCH, 59, 231-233. doi:10.1007/s00011-009-0136-1
Assem, E. -. S., Mann, S., Wan, B. Y. C., & Marson, C. M. (n.d.). Effect of some lipoic acid derivatives and other antioxidants on the histamine-induced guinea-pig tracheal smooth muscle contraction.
Assem, E. -. S., Peh, K. H., Wan, B. Y., Dines, J., Middleton, J. B., & Marson, C. M. (2009). Effects of a selection of histone deacetylase inhibitors on the antigen- and agonist(s)-induced tracheal smooth muscle contraction. Inflammation Research, 58, S22-S23.
Marson, C. M. (2009). Histone Deacetylase Inhibitors: Design, Structure-Activity Relationships and Therapeutic Implications for Cancer. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 9 (6), 661-692.
MARSON, C. (2009). Mode of Action of Histone Deacetylase Inhibitors on Mast Cell Histamine Release and Colon Muscle Contraction. Inflammation Research, 58, S24-S25.
Assem, E. -. S. K., Peh, K. H., Wan, B. Y. C., Middleton, B. J., Dines, J., & Marson, C. M. (2008). Effects of a selection of histone deacetylase inhibitors on mast cell activation and airway and colonic smooth muscle contraction. INTERNATIONAL IMMUNOPHARMACOLOGY, 8 (13-14), 1793-1801. doi:10.1016/j.intimp.2008.08.017
Joel, S. P., & Marson, C. M. (2008). Histone deacetylase inhibitors.
Kwok, J. M. -. M., Myatt, S. S., Marson, C. M., Coombes, R. C., Constantinidou, D., & Lam, E. W. -. F. (2008). Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression. MOLECULAR CANCER THERAPEUTICS, 7 (7), 2022-2032. doi:10.1158/1535-7163.MCT-08-0188
Marson, C. M., Edaan, E., Morrell, J. M., Coles, S. J., Hursthouse, M. B., & Davies, D. T. (2007). A catalytic asymmetric protocol for the enantioselective synthesis of 3(2H)-furanones. Chemical Communications, 24, 2494-2496. doi:10.1039/b701548h
Marson, C. M., Mahadevan, T., Dines, J., Sengmany, S., Morrell, J. M., Alao, J. P., . . . Coombes, R. C. (2007). Structure-activity relationships of aryloxyalkanoic acid hydroxyamides as potent inhibitors of histone deacetylase. Bioorganic and Medicinal Chemistry Letters, 17 (1), 136-141. doi:10.1016/j.bmcl.2006.09.085
Marson, C. M., Edaan, E., Coles, S. J., Morrell, J. M., Hursthouse, M. B., & Davies, D. T. (n.d.). A catalytic asymmetric protocol for the enantioselective synthesis of 3(2H)-furanones.
Marson, C. M., Savy, P., Rioja, A. S., Mahadevan, T., Mikol, C., Veerupillai, A., . . . Joel, S. P. (2006). Aromatic Sulfide Inhibitors of Histone Deacetylase based on Arysulfinyl-2,4-dienoic Acid Hydroxyamides. Journal of Medicinal Chemistry, 49, 800-805. doi:10.1021/jm051010j
Marson, C. M., Mahadevan, T., Dines, J., Sengmany, S., Morrell, J. M., Alao, J. P., . . . Coombes, R. C. (2006). Stereodefined and Structure-Activity Relationships of Aryloxyalkanoic acid Hydroxyamides as Potent Inhibitors of Histone Deacetylase. BIOORG MED CHEM LETT, 16.